Literature DB >> 19552791

Reduced IFN-gamma- and enhanced IL-4-producing CD4+ cord blood T cells are associated with a higher risk for atopic dermatitis during the first 2 yr of life.

Gunda Herberth1, Joachim Heinrich, Stefan Röder, Adina Figl, Michael Weiss, Ulrike Diez, Michael Borte, Olf Herbarth, Irina Lehmann.   

Abstract

The aim of this study was to analyse whether altered cytokine production by cord blood (CB) T cells is of relevance regarding the development of allergic diseases during the first 2 yr of life independent from known or suspected risk factors for allergy. Within an ongoing birth cohort study (Life style - Immune System - Allergy; LISA) the cytokine production of PMA/ionomycin-stimulated CB cells was measured by intracellular cytokine staining. Data of 98 children from Leipzig and Munich with complete information on cytokine production at birth and allergic outcomes during the first 2 yr were analysed. Statistical analysis was performed using a regression model adjusted for gender, month of birth, parental history of atopy, parental education, exposure to environmental tobacco smoke, maternal smoking during pregnancy, renovation activities during pregnancy, pet ownership and study centre. During the first 2 yr of life, 17.3% of the children developed a physician-diagnosed atopic dermatitis. Children with reduced frequencies of interferon-gamma (IFN-gamma)-producing CD4(+) T cells in the CB (1st quartile) had a higher risk to develop atopic dermatitis (adjusted OR 5.16, 95% CI: 1.04-25.6). Furthermore, a high percentage of interleukin (IL)-4-producing T cells in CB in children from the Leipzig cohort were associated with an increased risk for atopic dermatitis (adjusted OR 8.92, 95% CI: 1.40-56.93 for the 90th percentile). CD8(+) cytokine-producing CB T cells had no relation to increased risk for atopic dermatitis. Low amounts of IFN-gamma and high amounts of IL-4-producing T cells at birth may enhance the risk of subsequent development of atopic dermatitis. (c) 2009 John Wiley & Sons A/S

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19552791     DOI: 10.1111/j.1399-3038.2009.00890.x

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  26 in total

1.  Therapeutic effects of recombinant Salmonella typhimurium harboring CCL22 miRNA on atopic dermatitis-like skin in mice.

Authors:  Won Suck Yoon; Seung Seok Lee; Yang Seok Chae; Yong Keun Park
Journal:  Exp Mol Med       Date:  2011-02-28       Impact factor: 8.718

2.  Suppression of inflammation by recombinant Salmonella typhimurium harboring CCL22 microRNA.

Authors:  Won Suck Yoon; Seung Rel Ryu; Seung Seok Lee; Yang Seok Chae; Eun Jae Kim; Ji Hyun Choi; Sejin Oh; Se Ho Park; Ji Tae Choung; Young Yoo; Yong Keun Park
Journal:  DNA Cell Biol       Date:  2011-08-08       Impact factor: 3.311

3.  Relationships among environmental exposures, cord blood cytokine responses, allergy, and wheeze at 1 year of age in an inner-city birth cohort (Urban Environment and Childhood Asthma study).

Authors:  Robert A Wood; Gordon R Bloomberg; Meyer Kattan; Kathleen Conroy; Megan T Sandel; Amy Dresen; Peter J Gergen; Diane R Gold; John C Schwarz; Cynthia M Visness; James E Gern
Journal:  J Allergy Clin Immunol       Date:  2011-02-18       Impact factor: 10.793

4.  Th2 Cytokines and Atopic Dermatitis.

Authors:  Eric B Brandt; Umasundari Sivaprasad
Journal:  J Clin Cell Immunol       Date:  2011-08-10

Review 5.  The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies.

Authors:  Patrick M Brunner; Emma Guttman-Yassky; Donald Y M Leung
Journal:  J Allergy Clin Immunol       Date:  2017-04       Impact factor: 10.793

6.  Oxymatrine Sensitizes the HaCaT Cells to the IFN-γ Pathway and Downregulates MDC, ICAM-1, and SOCS1 by Activating p38, JNK, and Akt.

Authors:  Chun-Jie Gao; Pei-Jun Ding; Li-Li Yang; Xu-Feng He; Meng-Jiao Chen; Dong-Ming Wang; Yan-Xin Tian; Hui-Min Zhang
Journal:  Inflammation       Date:  2018-03       Impact factor: 4.092

7.  Relationship of secondhand smoke and infant lower respiratory tract infection severity by familial atopy status.

Authors:  Meghan Lemke; Tina V Hartert; Tebeb Gebretsadik; Kecia N Carroll
Journal:  Ann Allergy Asthma Immunol       Date:  2013-06       Impact factor: 6.347

8.  Early pediatric atopic dermatitis shows only a cutaneous lymphocyte antigen (CLA)(+) TH2/TH1 cell imbalance, whereas adults acquire CLA(+) TH22/TC22 cell subsets.

Authors:  Tali Czarnowicki; Hitokazu Esaki; Juana Gonzalez; Dana Malajian; Avner Shemer; Shinji Noda; Sreya Talasila; Adam Berry; Jayla Gray; Lauren Becker; Yeriel Estrada; Hui Xu; Xiuzhong Zheng; Mayte Suárez-Fariñas; James G Krueger; Amy S Paller; Emma Guttman-Yassky
Journal:  J Allergy Clin Immunol       Date:  2015-08-01       Impact factor: 10.793

9.  Evolution of pathologic T-cell subsets in patients with atopic dermatitis from infancy to adulthood.

Authors:  Tali Czarnowicki; Helen He; Talia Canter; Joseph Han; Rachel Lefferdink; Taylor Erickson; Stephanie Rangel; Naoya Kameyama; Hyun Je Kim; Ana B Pavel; Yeriel Estrada; James G Krueger; Amy S Paller; Emma Guttman-Yassky
Journal:  J Allergy Clin Immunol       Date:  2019-10-15       Impact factor: 10.793

Review 10.  Maternal Nutritional Status and Development of Atopic Dermatitis in Their Offspring.

Authors:  Chun-Min Kang; Bor-Luen Chiang; Li-Chieh Wang
Journal:  Clin Rev Allergy Immunol       Date:  2021-10       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.